2006
DOI: 10.1016/j.jaad.2005.10.046
|View full text |Cite
|
Sign up to set email alerts
|

UV hardening therapy: A novel intervention in patients with photosensitive cutaneous lupus erythematosus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0
1

Year Published

2007
2007
2015
2015

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 19 publications
(13 citation statements)
references
References 24 publications
0
12
0
1
Order By: Relevance
“…Radiation sources and their emission spectrum, filters, the UV intensity measuring, and calibration have been described previously. [6][7][8][9]13,14 The final diagnosis of a photosensitivity disorder was based on both the clinical features and the phototest results.…”
Section: Phototesting Proceduresmentioning
confidence: 99%
See 2 more Smart Citations
“…Radiation sources and their emission spectrum, filters, the UV intensity measuring, and calibration have been described previously. [6][7][8][9]13,14 The final diagnosis of a photosensitivity disorder was based on both the clinical features and the phototest results.…”
Section: Phototesting Proceduresmentioning
confidence: 99%
“…6,7 This included 5 children with PLE, 3 children with PhAD, one child with an ambiguous photosensitivity (PLE and PhAD), and one child with AP. Because of the retrospective nature of our study it was not possible to evaluate the effect of this therapy.…”
Section: Therapymentioning
confidence: 99%
See 1 more Smart Citation
“…Longer-wavelength UVA1 (340 --400 nm) seems less likely to flare the disease and may even be beneficial. Several small trials using low-dose UVA1 (6 --12 J/cm 2 ) have demonstrated benefit in systemic symptoms of SLE [58,59]. There are no published trials using UVA-1 specifically for CLE.…”
Section: Ivigmentioning
confidence: 99%
“…In a retrospective study of continuous, homebased, UVB hardening therapy, 44 patients with confirmed photosensitivity and cutaneous manifestations of LE were included (9 SLE, 21 DLE, 10 SCLE, 4 not-specified CLE). 58 Exposure to the UVB source was performed year-round, 3 times weekly with increasing doses. In all, 35 patients were able to gradually increase their monthly UVB dose and maintained their increased UVB tolerance over longer periods of time.…”
Section: Uva1 Therapymentioning
confidence: 99%